Kuliev Anver, Verlinsky Yury
Reproductive Genetics Institute, 2825 North Halsted Street, Chicago, IL 60657, USA.
Expert Rev Mol Diagn. 2005 Jul;5(4):499-505. doi: 10.1586/14737159.5.4.499.
Despite its novelty, preimplantation genetic diagnosis has become an alternative to traditional prenatal diagnosis, allowing the establishment of only unaffected pregnancies and avoiding the risk of pregnancy termination. In addition, preimplantation genetic diagnosis is presently applied for much wider indications than prenatal diagnosis, including common diseases with genetic predisposition and preimplantation human leukocyte antigen typing, with the purpose of establishing potential donor progeny for stem cell treatment of siblings. Many hundreds of apparently healthy, unaffected children have been born after preimplantation genetic diagnosis, presenting evidence of its accuracy, reliability and safety. Preimplantation genetic diagnosis appears to be of special value for avoiding age-related aneuploidies in patients of advanced reproductive age, improving reproductive outcome, particularly obvious from their reproductive history, and is presently an extremely attractive option for carriers of balanced translocations to have unaffected children of their own.
尽管植入前基因诊断尚属新奇技术,但它已成为传统产前诊断的一种替代方法,能够仅促成未受影响的妊娠,并避免终止妊娠的风险。此外,目前植入前基因诊断的应用指征比产前诊断广泛得多,包括具有遗传易感性的常见疾病以及植入前人类白细胞抗原分型,目的是为同胞的干细胞治疗建立潜在的供体后代。数百名明显健康、未受影响的儿童在植入前基因诊断后出生,证明了其准确性、可靠性和安全性。植入前基因诊断对于避免高龄育龄患者与年龄相关的非整倍体、改善生殖结局似乎具有特殊价值,从他们的生殖史来看尤为明显,并且目前对于平衡易位携带者而言,是拥有自己未受影响孩子的极具吸引力的选择。